Reprints Desk, Inc., a Derycz Scientific company, has announced the public availability of Bibliogo, the journal article web app that helps users do more with scientific papers. Bibliogo, available in free and paid versions, is built to scale using Google App Engine and is a productivity tool designed for professionals and workgroups in research, bioinformatics, engineering, information management, regulatory and medical affairs, medical marketing and healthcare communications.
According to Ian Palmer, Head of Marketing at Reprints Desk and Derycz Scientific, the app combines aspects from personalised RSS-readers and alerting services, bibliographic reference management software, daily deal websites for clinical reprints, and document delivery management systems. Sample article use cases and benefits made possible by Bibliogo include saving time for scientists, engineers, pharmacovigilance professionals, and others by enabling them to follow and access new articles in journals and saved database searches; simplifying processes for librarians and searchers to find, manage, and securely share citations with internal end users via alerts and newsletters; and saving time for product brand managers and healthcare communications agencies by serving as a one-stop shop for requesting quotes and placing orders for clinical reprints from any publisher.
Additionally, Bibliogo will also help enhance compliance controls for regulatory affairs professionals by enabling them to set-up bibliographies of articles approved for reactive distribution by medical information teams and pro-active distribution by sales and marketing teams. Further, it helps organisations to save money by enabling them to identify paid subscription content for research, placing document delivery orders without any rush fees, and leveraging group buying power for reprints used in marketing.
Prior to its public availability, Bibliogo has had multiple deployments across the Pharmaceutical, Biotech, and Medical Device industries.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visitwww.myscoope.com for a mobile friendly reading experience.
More News in this Theme
